CALCITONIN MIMETICS FOR TREATING DISEASES AND DISORDERS

A pharmaceutical co-formulation comprising a calcitonin mimetic and an insulin sensitiser, and its use in the treatment type I diabetes, type II diabetes or a metabolic syndrome, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HENRIKSEN Kim, MEHTA Nozer M, KARSDAL Morten Asser, STURMER Amy M, STERN William
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A pharmaceutical co-formulation comprising a calcitonin mimetic and an insulin sensitiser, and its use in the treatment type I diabetes, type II diabetes or a metabolic syndrome, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.